Evidence map›Paper›PMID 35092004›Full record

ArticleActa obstetricia et gynecologica Scandinavica2022

Implementation of a revised classification for intrapartum fetal heart rate monitoring and association to birth outcome: A national cohort study.

Maria Jonsson, Jonas Söderling, Lars Ladfors, Lennart Nordström, Marianne Nilsson, Michael Algovik, Mikael Norman, Malin Holzmann

Open access · diamondAbstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Maria JonssonDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0002-2657-1958
Jonas SöderlingDepartment of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
Lars LadforsInstitute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-7512-2059
Lennart NordströmDepartment Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-7547-2569
Marianne NilssonSahlgrenska University Hospital, Gothenburg, Sweden.
Michael AlgovikVästervik Hospital, Västervik, Sweden.
Mikael NormanDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Malin HolzmannDepartment Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-2640-0753
Karolinska Institutet · SEKarolinska University Hospital · SESahlgrenska University Hospital · SEOrnsköldsvik Hospital · SEUppsala University · SE

Funding

The Swedish Patient Insurance Company N/A
6 · The paper itself

Abstract

introductionA revised intrapartum cardiotocography (CTG) classification was introduced in Sweden in 2017. The aims of the revision were to adapt to the international guideline published in 2015 and to adjust the classification of CTG patterns to current evidence regarding intrapartum fetal physiology. This study aimed to investigate adverse neonatal outcomes before and after implementation of the revised CTG classification. MATERIAL AND

methodsA before-and-after design was used. Cohort I (n = 160 210) included births from June 1, 2014 through May 31, 2016 using the former CTG classification, and cohort II (n = 166 558) included births from June 1, 2018 through May 31, 2020 with the revised classification. Data were collected from the Swedish Pregnancy and Neonatal Registers. The primary outcome was moderate to severe neonatal hypoxic ischemic encephalopathy (HIE 2-3). Secondary outcomes were birth acidemia (umbilical artery pH <7.05 and base excess < -12 mmol/L or pH <7.00), A-criteria for neonatal hypothermia treatment, 5-min Apgar scores <4 and <7, neonatal seizures, meconium aspiration, neonatal mortality and delivery mode. Logistic regression was used (period II vs period I), and results are presented as adjusted odds ratios (aORs) with 95% confidence intervals (95% CIs).

resultsThere were no statistically significant differences in HIE 2-3 (aOR 1.27; 95% CI 0.97-1.66), proportion of neonates meeting A-criteria for hypothermia treatment (aOR 0.96; 95% CI 0.89-1.04) or neonatal mortality (aOR 0.68; 95% CI 0.39-1.18) between the cohorts. Birth acidemia (aOR 1.36; 95% CI 1.25-1.48), 5-min Apgar scores <7 (aOR 1.27; 95% CI 1.18-1.36) and <4 (aOR 1.40; 95% CI 1.17-1.66) occurred more often in cohort II. The absolute risk difference for HIE 2-3 was 0.02% (95% CI 0.00-0.04). Operative delivery (vacuum or cesarean) rates were lower in cohort II (aOR 0.82; 95% CI 0.80-0.85 and aOR 0.94; 95% CI 0.91-0.97, respectively).

conclusionsAlthough not statistically significant, a small increase in the incidence of HIE 2-3 after implementation of the revised CTG classification cannot be excluded. Operative deliveries were fewer but incidences of acidemia and low Apgar scores were higher in the latter cohort. This warrants further in-depth analyses before a full re-evaluation of the revised classification can be made.

Indexed as

Practice Guidelines as TopicAdultCardiotocographyCohort StudiesFemaleHumansInfantInfant MortalityInfant, NewbornMalePregnancyPregnancy OutcomePrenatal CareRegistriesSwedencardiotocographyfetal acidemiafetal heart rate monitoringfetal hypoxiafetal monitoringfetal surveillanceguidelinehypoxic ischemic encephalopathyobstetric labor

Identifiers

PMID35092004
PMCPMC9564816
OpenAlexW4210698910

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.